Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In the SURMOUNT-1 obesity trial, tirzepatide produced mean weight reductions of roughly 1521% depending on dose over 72 weeks ( Jastreboff et al., NEJM 2022
doi: 10.2147/IDR.S256773 169 LinaniA.BenarousK.Bou-SalahL.YousfiM.Goumri-SaidS
Skipping a dose can increase the risk of a dangerous clot
"And it's not because of any magic it's because these are natural substances that our bodies make and are familiar with, so that's what gives them this incredible safety profile." The FDA, however, has publicly stated that there is not enough evidence from human clinical trials on the safety or efficacy of these drugs
GHK-Cu (100 mg)
Using an insulin syringe, draw the calculated volume of bacteriostatic water (typically 2 mL)
US$ 21.30
US$ 27.96
US$ 24.11
US$ 22.83
US$ 28.46
US$ 26.53
US$ 21.24
